110 related articles for article (PubMed ID: 34887369)
1. Associations of whole-body 18F-FDG PET/CT parameters and SCC-Ag level with overall survival in patients with cervical cancer.
Guan L; Zuo R; Wang Z; Xu L; Liu S; Pang H
Nucl Med Commun; 2022 Jan; 43(1):49-55. PubMed ID: 34887369
[TBL] [Abstract][Full Text] [Related]
2. Predicting epithelial ovarian cancer prognosis: correlation of posttreatment
Yang L; Li M; Liang H; Wang X; Guan L; Jing X
Quant Imaging Med Surg; 2024 Jan; 14(1):972-985. PubMed ID: 38223064
[TBL] [Abstract][Full Text] [Related]
3. The prognostic role of 18F-FDG PET/CT baseline quantitative metabolic parameters in peripheral T-cell lymphoma.
Xia J; Zhu HY; Liang JH; Ding CY; Wang L; Wu W; Cao L; Li TL; Li JY; Xu W
J Cancer; 2019; 10(23):5805-5811. PubMed ID: 31737117
[No Abstract] [Full Text] [Related]
4. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC).
Mirili C; Guney IB; Paydas S; Seydaoglu G; Kapukaya TK; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M
Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.
Kim CY; Hong CM; Kim DH; Son SH; Jeong SY; Lee SW; Lee J; Ahn BC
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1321-9. PubMed ID: 23674211
[TBL] [Abstract][Full Text] [Related]
6. The ratio between the whole-body and primary tumor burden, measured on
Oliveira FRA; Santos AO; de Lima MDCL; Toro IFC; de Souza TF; Amorim BJ; Barbeiro AS; Etchebehere E
Radiol Bras; 2021; 54(5):289-294. PubMed ID: 34602663
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of
Choi EK; Park M; Im JJ; Chung YA; Oh JK
J Int Med Res; 2020 Apr; 48(4):300060519892419. PubMed ID: 31880209
[TBL] [Abstract][Full Text] [Related]
8. Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
Kim CY; Jeong SY; Chong GO; Son SH; Jung JH; Kim DH; Lee SW; Ahn BC; Lee J
Gynecol Oncol; 2015 Mar; 136(3):498-504. PubMed ID: 25557270
[TBL] [Abstract][Full Text] [Related]
9. Prognostic predictive value of total lesion glycolysis from 18F-FDG PET/CT in post-surgical patients with epithelial ovarian cancer.
Liao S; Lan X; Cao G; Yuan H; Zhang Y
Clin Nucl Med; 2013 Sep; 38(9):715-20. PubMed ID: 23856825
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of (18)F-FDG PET/CT volumetric parameters in recurrent epithelial ovarian cancer.
Mayoral M; Fernandez-Martinez A; Vidal L; Fuster D; Aya F; Pavia J; Pons F; Lomeña F; Paredes P
Rev Esp Med Nucl Imagen Mol; 2016; 35(2):88-95. PubMed ID: 26541072
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of metabolic parameters measured by
Mathew B; Purandare NC; Puranik A; Shah S; Agrawal A; Pramesh CS; Karimundackal G; Jiwnani S; Rangarajan V
World J Nucl Med; 2020; 19(1):8-14. PubMed ID: 32190016
[No Abstract] [Full Text] [Related]
12. Utility of baseline, interim and end-of-treatment
Chang Y; Fu X; Sun Z; Xie X; Wang R; Li Z; Zhang X; Sheng G; Zhang M
Sci Rep; 2017 Jan; 7():41057. PubMed ID: 28117395
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Nasopharyngeal Carcinoma Patients after Comprehensive Therapy.
Tian Y; Bakari KH; Liao S; Xia X; Sun X; Qin C; Zhang Y; Lan X
Contrast Media Mol Imaging; 2018; 2018():1384281. PubMed ID: 29681779
[TBL] [Abstract][Full Text] [Related]
14. Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer.
Oh JR; Seo JH; Chong A; Min JJ; Song HC; Kim YC; Bom HS
Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):925-35. PubMed ID: 22270509
[TBL] [Abstract][Full Text] [Related]
15. Metabolic parameters of [
Markus M; Sartor H; Bjurberg M; Trägårdh E
Acta Oncol; 2023 Feb; 62(2):180-188. PubMed ID: 36815676
[TBL] [Abstract][Full Text] [Related]
16. Correlation of
Mayoral M; Paredes P; Saco A; Fusté P; Perlaza P; Tapias A; Fernandez-Martinez A; Vidal L; Ordi J; Pavia J; Martinez-Roman S; Lomeña F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):80-86. PubMed ID: 28869177
[TBL] [Abstract][Full Text] [Related]
17. Different Prognostic Implications of 18F-FDG PET Between Histological Subtypes in Patients With Cervical Cancer.
Rahman T; Tsujikawa T; Yamamoto M; Chino Y; Shinagawa A; Kurokawa T; Tsuchida T; Kimura H; Yoshida Y; Okazawa H
Medicine (Baltimore); 2016 Mar; 95(9):e3017. PubMed ID: 26945427
[TBL] [Abstract][Full Text] [Related]
18. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
Sun Y; Lu P; Yu L
Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.
Albano D; Bertoli M; Battistotti M; Rodella C; Statuto M; Giubbini R; Bertagna F
Ann Nucl Med; 2018 Oct; 32(8):532-541. PubMed ID: 29982990
[TBL] [Abstract][Full Text] [Related]
20. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
